Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles]“Clinical application of DDS in cancer chemotherapy” Editor:Tetsuya Hamaguchi
Nanoliposomal irinotecan for patients with metastatic pancreatic cancer
Yoshiyuki Yamamoto
Author information
Keywords: Onyvide, irinotecan, liposome, pancreatic cancer
JOURNAL FREE ACCESS

2017 Volume 32 Issue 2 Pages 109-118

Details
Download PDF (684K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

Some anticancer agents-incorporating liposomes have been developed and exhibited the clinical benefits. Recently, a novel nanoliposomal formulation of irinotecan (Onyvide®) has been approved in combination with 5―FU and leucovorin for the treatment of patients with metastatic pancreatic cancer. In this review, we introduce the characteristics and clinical trials of the nanoliposomal irinotecan.

Content from these authors
© 2017 The Japan Society of Drug Delivery System
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top